Hypertension and risk of prostate cancer: a systematic review and meta-analysis

Zhen Liang(Capital Medical University), Liping Xie(First Affiliated Hospital Zhejiang University), Song Wang(Ministry of Education), Xin Xu(Shanghai University of Sport), Alin Ji(Zhejiang Provincial People's Hospital), Xiao Wang(Qingdao University), Yi Zhu(Mayo Clinic in Arizona), Bo Xie(First Affiliated Hospital Zhejiang University), Xiangyi Zheng(Tianjin University), Jiangfeng Li(ShanghaiTech University), Shuai Meng(Capital Medical University)
Scientific Reports
August 11, 2016
10.1038/srep31358
Cited by 108

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188